| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.25B | 2.37B | 2.17B | 1.20B | 2.05B | 858.00M |
| Gross Profit | 1.53B | 1.71B | 1.64B | 741.00M | 1.68B | 541.00M |
| EBITDA | 1.43B | 1.59B | 1.54B | 655.00M | 1.60B | 503.00M |
| Net Income | 1.36B | 1.52B | 1.52B | 600.00M | 1.57B | 484.00M |
Balance Sheet | ||||||
| Total Assets | 30.81B | 28.25B | 23.80B | 22.40B | 20.84B | 16.20B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 635.00M | 535.00M | 303.00M | 372.00M | 254.00M |
| Total Debt | 15.61B | 13.76B | 11.95B | 12.38B | 11.16B | 8.60B |
| Total Liabilities | 16.48B | 14.90B | 12.60B | 12.84B | 11.97B | 9.02B |
| Stockholders Equity | 14.32B | 13.36B | 11.20B | 9.55B | 8.87B | 7.18B |
Cash Flow | ||||||
| Free Cash Flow | 1.30B | 1.28B | 1.00B | 746.00M | 935.00M | 734.00M |
| Operating Cash Flow | 1.30B | 1.28B | 1.00B | 746.00M | 935.00M | 734.00M |
| Investing Cash Flow | -2.86B | -3.41B | -489.00M | -2.10B | -3.39B | -1.29B |
| Financing Cash Flow | 2.19B | 2.42B | -284.00M | 1.21B | 2.62B | 707.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $3.38B | 10.82 | 15.21% | 10.00% | -15.32% | -12.29% | |
77 Outperform | $14.77B | 10.37 | 10.06% | 9.64% | 10.34% | -24.16% | |
77 Outperform | $5.48B | 10.14 | 19.07% | 7.17% | 11.60% | 9.38% | |
68 Neutral | $25.25B | 697.18 | 7.19% | 3.03% | 25.02% | 235.70% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | $3.61B | 9.67 | 9.42% | 11.70% | 24.12% | 1.09% | |
60 Neutral | $4.08B | 15.00 | 4.24% | 18.52% | -13.67% | -48.49% |
On January 12, 2026, Ares Capital Corporation completed the issuance and sale of $750 million aggregate principal amount of 5.250% unsecured notes due April 12, 2031, under a supplemental indenture with U.S. Bank Trust Company, National Association as trustee. The notes, which pay interest semiannually starting April 12, 2026, include covenants tied to Investment Company Act leverage requirements, reporting obligations if Ares Capital ceases to be an Exchange Act filer, and a change-of-control repurchase feature if the notes are downgraded below investment grade by all three major rating agencies. Ares Capital intends to use the net proceeds to repay borrowings under its credit facilities, with capacity to reborrow for general corporate purposes including new portfolio investments, thereby optimizing its liability structure and preserving funding flexibility. In a related step, on January 5, 2026, the company entered into a purchase agreement with a syndicate of underwriters for the notes and simultaneously executed a $750 million interest rate swap with SMBC Capital Markets, Inc., converting its fixed 5.250% coupon into a floating rate based on one‑month SOFR plus 1.7217% through April 12, 2031, which aligns its funding costs more closely with short-term rates and may reduce interest rate risk.
The most recent analyst rating on (ARCC) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.
On December 3, 2025, Ares Capital Corporation completed a $1.0 billion term debt securitization through its subsidiary, Ares Direct Lending CLO 7 LLC. This transaction, known as the ADL CLO 7 Debt Securitization, involves issuing various classes of notes backed by a diversified portfolio of first lien senior secured loans. The company plans to use the proceeds to repay outstanding debt and invest in portfolio companies, enhancing its financial flexibility and strategic positioning in the market.
The most recent analyst rating on (ARCC) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.
On October 28, 2025, Ares Capital Corporation announced its financial results for the third quarter ending September 30, 2025, and declared a fourth quarter dividend of $0.48 per share, payable on December 30, 2025. The company’s financial performance showed a slight decrease in GAAP net income per share compared to the previous year, with net investment income also declining. However, the company’s portfolio investments and total assets increased, indicating a robust market position.
The most recent analyst rating on (ARCC) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.